Autopsy report · NCT02825719
Ulipristal Use in Chinese Population
Cause of deathDrug or device supply
“Ulipristal was withdrawal from the market”
Life of this trial
- Registered 6 months after it had already started.
- Ran for about 4 years 4 months before it stopped.
- 31 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Queen Mary Hospital, Hong Kong
- Sponsor type
- University, hospital or other
- Conditions
- Fibroid
- Interventions
- Ulipristal acetate; Placebo pills; Ferrous sulphate; Tranexamic Acid
- Participants
- 31
- Sites
- 1
- Countries
- Hong Kong
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.